Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...

Famciclovir. A prodrug of penciclovir, famciclovir does not have a major role in the treatment of chronic hepatitis B because of its low efficacy compared with lamivudine. Adefovir dipivoxil.

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Aim: The study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral ...

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

In our treatment cohort, of 76 patients with pretreatment serum HBV DNA < 200 IU/mL, reappearance of HBV DNA was found in 47 (61.8%) patients. [9] These patients should be monitored regularly and ...

Methods: A multi-center prospective observational study was conducted involving 59 NAs-treated chronic hepatitis B (CHB) patients who were treated with a combination therapy of NAs and Peg-IFN-α-2b ...

emphasizing progress in its efforts to develop a functional cure for chronic hepatitis B (cHBV). “We enter 2025 with solid financial footing and strong momentum in achieving our mission of ...